Showing results (41-50 of 79) with videos related to

Sort By:
Pageof 8
Experimental Hematology & Oncology|July 19, 2023
Fibronectin promotes tumor angiogenesis and progression of non-small-cell lung cancer by elevating WISP3 expression via FAK/MAPK/ HIF-1α axis and activating wnt signaling pathwayFei Zhou, Jianguo Sun, Lingyun Ye, et al.
Annals of Translational Medicine|April 21, 2020
Killer immunoglobulin-like receptors/human leukocyte antigen class-I, a crucial immune pathway in cancerYi Xu, Lei Wang, Wei Li, et al.
Journal of Hematology & Oncology|June 24, 2020
cGAS-STING, an important pathway in cancer immunotherapyMinlin Jiang, Peixin Chen, Lei Wang, et al.
Translational Lung Cancer Research|May 19, 2020
Immunotherapy as a treatment for small cell lung cancer: a case report and brief reviewYan Wu, Yu Liu, Chenglong Sun, et al.
Human Vaccines & Immunotherapeutics|January 6, 2026
Healthcare providers' awareness, attitudes, beliefs, and practices surrounding pharmacist-administered vaccination: Insights after a two-year interventionAntonia M Di Castri, Donna M Halperin, Jennifer E Isenor, et al.
Translational Lung Cancer Research|July 18, 2020
Mechanisms of drugs-resistance in small cell lung cancer: DNA-related, RNA-related, apoptosis-related, drug accumulation and metabolism procedurePeixin Chen, Peng Kuang, Lei Wang, et al.
Vaccine|December 23, 2023
An enveloped virus-like particle alum-adjuvanted cytomegalovirus vaccine is safe and immunogenic: A first-in-humans Canadian Immunization Research Network (CIRN) studyJoanne M Langley, Soren Gantt, Scott A Halperin, et al.
BMC Public Health|December 6, 2025
The impact of two-year community-wide pharmacy interventions on the public's knowledge, attitudes, beliefs and behaviors about pharmacists as immunizersDonna M Halperin, Antonia M Di Castri, Jennifer E Isenor, et al.
Translational Lung Cancer Research|November 4, 2021
Real-world outcomes of chemo-antiangiogenesis versus chemo-immunotherapy combinations in EGFR-mutant advanced non-small cell lung cancer patients after failure of EGFR-TKI therapyXin Yu, Jiaqi Li, Lingyun Ye, et al.
The Journal of Infectious Diseases|April 5, 2018
A Respiratory Syncytial Virus Vaccine Based on the Small Hydrophobic Protein Ectodomain Presented With a Novel Lipid-Based Formulation Is Highly Immunogenic and Safe in Adults: A First-in-Humans StudyJoanne M Langley, Lisa D MacDonald, Genevieve M Weir, et al.
Pageof 8